| A recombinant vesicular stomatitis virus Ebola vaccine JA Regules, JH Beigel, KM Paolino, J Voell, AR Castellano, Z Hu, ... New England Journal of Medicine 376 (4), 330-341, 2017 | 446 | 2017 |
| VSV-Ebola Consortium 2015 A Huttner, JA Dayer, S Yerly, C Combescure, F Auderset, J Desmeules, ... The effect of dose on the safety and immunogenicity of the VSV Ebola …, 2015 | 314* | 2015 |
| Matrix-M adjuvant enhances antibody, cellular and protective immune responses of a Zaire Ebola/Makona virus glycoprotein (GP) nanoparticle vaccine in mice KL Bengtsson, H Song, L Stertman, Y Liu, DC Flyer, MJ Massare, RH Xu, ... Vaccine 34 (16), 1927-1935, 2016 | 122 | 2016 |
| Respiratory syncytial virus grown in Vero cells contains a truncated attachment protein that alters its infectivity and dependence on glycosaminoglycans S Kwilas, RM Liesman, L Zhang, E Walsh, RJ Pickles, ME Peeples Journal of virology 83 (20), 10710-10718, 2009 | 120 | 2009 |
| Assessing the safety and immunogenicity of recombinant vesicular stomatitis virus Ebola vaccine in healthy adults: a randomized clinical trial MS ElSherif, C Brown, D MacKinnon-Cameron, L Li, T Racine, J Alimonti, ... Cmaj 189 (24), E819-E827, 2017 | 82 | 2017 |
| Crimean–Congo hemorrhagic fever virus utilizes a clathrin-and early endosome-dependent entry pathway AR Garrison, SR Radoshitzky, KP Kota, G Pegoraro, G Ruthel, JH Kuhn, ... Virology 444 (1-2), 45-54, 2013 | 80 | 2013 |
| Codon-optimized filovirus DNA vaccines delivered by intramuscular electroporation protect cynomolgus macaques from lethal Ebola and Marburg virus challenges RJ Grant-Klein, LA Altamura, CV Badger, CE Bounds, NM Van Deusen, ... Human vaccines & immunotherapeutics 11 (8), 1991-2004, 2015 | 79 | 2015 |
| DNA vaccine–derived human IgG produced in transchromosomal bovines protect in lethal models of hantavirus pulmonary syndrome JW Hooper, RL Brocato, SA Kwilas, CD Hammerbeck, MD Josleyn, ... Science translational medicine 6 (264), 264ra162-264ra162, 2014 | 77 | 2014 |
| Preclinical development of inactivated rabies virus–based polyvalent vaccine against rabies and filoviruses M Willet, D Kurup, A Papaneri, C Wirblich, JW Hooper, SA Kwilas, ... The Journal of infectious diseases 212 (suppl_2), S414-S424, 2015 | 70 | 2015 |
| A hantavirus pulmonary syndrome (HPS) DNA vaccine delivered using a spring-powered jet injector elicits a potent neutralizing antibody response in rabbits and nonhuman primates S Kwilas, J M Kishimori, M Josleyn, K Jerke, J Ballantyne, M Royals, ... Current gene therapy 14 (3), 200-210, 2014 | 68 | 2014 |
| Adjuvant-enhanced CD4 T cell responses are critical to durable vaccine immunity KAO Martins, CL Cooper, SM Stronsky, SLW Norris, SA Kwilas, ... EBioMedicine 3, 67-78, 2016 | 61 | 2016 |
| Interaction between respiratory syncytial virus and glycosaminoglycans, including heparan sulfate LK Hallak, SA Kwilas, ME Peeples Glycovirology protocols, 15-34, 2007 | 59 | 2007 |
| Antiviral biologic produced in DNA vaccine/goose platform protects hamsters against hantavirus pulmonary syndrome when administered post-exposure N Haese, RL Brocato, T Henderson, ML Nilles, SA Kwilas, MD Josleyn, ... PLoS neglected tropical diseases 9 (6), e0003803, 2015 | 52 | 2015 |
| Aetiology of influenza-like illness in adults includes parainfluenzavirus type 4 H Hasman, CT Pachucki, A Unal, D Nguyen, T Devlin, ME Peeples, ... Journal of medical microbiology 58 (4), 408-413, 2009 | 46 | 2009 |
| Protective efficacy of a SARS-CoV-2 DNA vaccine in wild-type and immunosuppressed Syrian hamsters RL Brocato, SA Kwilas, RK Kim, X Zeng, LM Principe, JM Smith, ... npj Vaccines 6 (1), 16, 2021 | 44 | 2021 |
| Randomized, blinded, dose-ranging trial of an Ebola virus glycoprotein nanoparticle vaccine with matrix-m adjuvant in healthy adults L Fries, I Cho, V Krähling, SK Fehling, T Strecker, S Becker, JW Hooper, ... The Journal of Infectious Diseases 222 (4), 572-582, 2020 | 41 | 2020 |
| Lipid nanoparticle formulation increases efficiency of DNA-vectored vaccines/immunoprophylaxis in animals including transchromosomic bovines EM Mucker, PP Karmali, J Vega, SA Kwilas, H Wu, M Joselyn, ... Scientific reports 10 (1), 8764, 2020 | 41 | 2020 |
| Production of potent fully human polyclonal antibodies against Ebola Zaire virus in transchromosomal cattle JM Dye, H Wu, JW Hooper, S Khurana, AI Kuehne, EM Coyle, RA Ortiz, ... Scientific Reports 6 (1), 24897, 2016 | 41 | 2016 |
| Characterization of Ebola convalescent plasma donor immune response and psoralen treated plasma in the United States CL Dean, JW Hooper, JM Dye, SE Zak, SA Koepsell, L Corash, ... Transfusion 60 (5), 1024-1031, 2020 | 37 | 2020 |
| Cross-protection conferred by filovirus virus-like particles containing trimeric hybrid glycoprotein K Martins, JH Carra, CL Cooper, SA Kwilas, CG Robinson, AC Shurtleff, ... Viral immunology 28 (1), 62-70, 2015 | 30 | 2015 |
